Funding announcement
Azura heads for final studies for world-first dry eye treatment
Brandon Capital's blog republishes an AFR report on Azura Ophthalmics' encouraging phase 2 dry-eye results, recalling the Israel-founded biotech's US$38 million raised, among it a US$16 million round that Brandon Capital's fund co-led.